Showing results (371-380 of 406) with videos related to

Sort By:
Pageof 41
Allergy|April 9, 2023
Dupilumab but not cyclosporine treatment shifts the microbiome toward a healthy skin flora in patients with moderate-to-severe atopic dermatitisJan Hartmann, Lucas Moitinho-Silva, Nicole Sander, et al.
Allergy|July 22, 2020
Efficacy and safety of dupilumab for moderate-to-severe atopic dermatitis: A systematic review for the EAACI biologicals guidelinesIoana Agache, Yang Song, Margarita Posso, et al.
Skin Health and Disease|November 28, 2025
Large Eczema Area and Severity Index response at 2-year follow-up of patients treated with dupilumab in routine care of atopic dermatitis: results from the national registry TREATgermanyLuise Heinrich, Thomas Birkner, Susanne Abraham, et al.
Contact Dermatitis|March 17, 2021
European Surveillance System on Contact Allergies (ESSCA): Characteristics of patients patch tested and diagnosed with irritant contact dermatitisLaura Loman, Wolfgang Uter, José C Armario-Hita, et al.
The Journal of Allergy and Clinical Immunology|March 1, 2017
Effects of structured patient education in adults with atopic dermatitis: Multicenter randomized controlled trialAnnice Heratizadeh, Thomas Werfel, Andreas Wollenberg, et al.
The Journal of Allergy and Clinical Immunology|July 12, 2015
International consensus on allergy immunotherapyMarek Jutel, Ioana Agache, Sergio Bonini, et al.
Allergologie Select|July 15, 2021
Update of the S2k guideline on the management of IgE-mediated food allergiesMargitta Worm, Imke Reese, Barbara Ballmer-Weber, et al.
Allergy|August 9, 2020
Efficacy and safety of treatment with omalizumab for chronic spontaneous urticaria: A systematic review for the EAACI Biologicals GuidelinesIoana Agache, Claudio Rocha, Ana Pereira, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|April 25, 2024
Obesity is linked to disease severity in moderate to severe atopic dermatitis-Data from the prospective observational TREATgermany registryStephan Traidl, Moritz M Hollstein, Nadine Kroeger, et al.
Skin Health and Disease|June 30, 2025
A pan-European register-based observational study of abrocitinib and conventional systemic therapies in moderate and severe atopic dermatitis: the DREAM TO TREAT AD study protocolElizaveta Gribaleva, Niels Steen Krogh, David Prieto-Merino, et al.
Pageof 41